Plantar Fasciitis, ChronicBlind assessorNCT07672327
Efficacy of Short Wave and Laser Therapy in Patients With Plantar Fasciitis
A study testing conventional physical therapy, Extracorporeal shock wave therapy and High-intensity laser therapy in people with Plantar Fasciitis, Chronic, run by Ibrahim Abuomar Fadulaalhq Alramadhani at 1 site in Saudi Arabia.
Trial summary
Plantar fasciitis is a common painful condition. It accounts for 10-15% of all foot painful conditions. Recently, Extracorporeal shock wave therapy (ESWT) was used as an effective method in treatment of different musculoskeletal disorders. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- Plantar Fasciitis, Chronic
- What is being tested?
- conventional physical therapy, Extracorporeal shock wave therapy and High-intensity laser therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 1 Jun 2026to 1 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- 1. Patients will be included according to the diagnostic criteria for plantar fasciitis of the American physical therapy association (APTA) (Martin et al., 2014). This criterion includes pain in medial sole and heel of foot: most pronounced in initial steps after a period of inactivity, it also worsens after prolonged weight bearing, pain during palpation and compression of proximal plantar fascia, limited range of motion in active and passive ankle dorsiflexion, positive windlass test.
- 2. Patients will be referred from an orthopedic surgeon with confirmed diagnosis of plantar fasciitis (Bidoki et al., 2024).
- 3. Patients with chronic plantar fasciitis (Duration of patient's symptoms will be more than three months) (Riaz et al., 2023).
- 4. Patients' age will range from 18 to 45 years (Bidoki et al., 2024). 5. Both genders (Riaz et al., 2023). 6. Localized non radiating foot pain with an NPRS more than 5 on the first step in the morning (Riaz et al., 2023).
Who cannot join
- Patients will be excluded if they present any of the following criteria
- History of previous surgery of plantar fasciitis (Riaz et al., 2023).
- History of previous corticosteroid injections (Bidoki et al., 2024).
- History of heel pain due to previous trauma or calcaneus stress fracture in the last 3 months (Bidoki et al., 2024).
- History of previous lumbar spine surgery (Bidoki et al., 2024).
- History of rheumatologic disease (rheumatoid arthritis, diffuse idiopathic skeletal hyperostosis, systemic lupus erythematosus, gout, Sjogren disease, enthesopathy, etc…) (Bidoki et al., 2024).
- Pregnancy, pacemaker fitted or bleeding disorders (Bidoki et al., 2024).
- Wounds, infections or tumors in the treatment area (Bidoki et al., 2024).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Efficacy of Extracorporeal Shock Wave Therapy Versus High-intensity Laser Therapy in Patients With Plantar Fasciitis
Plantar fasciitis is a common painful condition. It accounts for 10-15% of all foot painful conditions. Recently, Extracorporeal shock wave therapy (ESWT) was used as an effective method in treatment of different musculoskeletal disorders. High-intensity laser therapy (HILT) is a relatively recent treatment option that has shown benefits in a wide range of musculoskeletal disorders.
- Conditions
- Plantar Fasciitis, Chronic
- Being tested
- conventional physical therapy, Extracorporeal shock wave therapy, High-intensity laser therapy
- Medical subject headings
- Fasciitis, Plantar
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
conventional physical therapyOther
exercise
Extracorporeal shock wave therapyOther
ESWT
High-intensity laser therapyOther
HILT
| Study group | Role | What they receive |
|---|---|---|
| Control group | Experimental | Group (A) Receives: Other: conventional physical therapy |
| Extracorporeal shock wave therapy | Experimental | Group (B) Receives: Other: Extracorporeal shock wave therapy |
| High-intensity laser therapy | Experimental | Group (C) Receives: Other: High-intensity laser therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hand held dynamometer
Hand held dynamometer is a portable device, characterized as a low-cost and convenience to assess muscle strength in a clinical setting
Measured: 6 weeks
Ultrasonography
Ultrasonography is a type of medical imaging device that uses high-frequency sound (ultrasound) waves to produce images of internal organs and other tissues such as tendons, muscles, joints, blood vessels, and internal organs, to measure some characteristics
Measured: 6 weeks
Arabic version of foot function index (FFI-Ar)
Foot functional index is a self-administered index consisting of 23 items divided into 3 subcategories on the basis of: pain, disability and activity limitation.
Measured: 6 weeks
Arabic version of numerical pain rating scale (NPRS-Ar)
The Numerical Rating Scale is an 11-point (0-10) Scale that measures pain intensity, it is considered a very sensitive pain assessment scale.
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2026
- Study start1 Jun 2026
- Primary completion1 Jun 2026
- Study completion1 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Plantar Fasciitis, ChronicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Model description
- 3 groups, each group consisted of 20 participants
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ibrahim Abuomar Fadulaalhq Alramadhani
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Ibrahim Abuomar Fadulaalhq Alramadhani, Umm Al-Qura University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07672327
- Sponsor's protocol ID
- P.T.REC/012/006509
- Acronym
- Blind assessor
- Status last verified
- Jun 2026
- First submitted
- 7 May 2026
- Last updated
- 26 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Because it is top secrets for them and they refused.
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Extracorporeal Shock Wave Therapy Versus High-intensity Laser Therapy in Patients With Plantar Fasciitis
- ClinicalTrials.gov ID
- NCT07672327
- Acronym / sponsor ID
- Blind assessor / P.T.REC/012/006509
- Conditions
- Plantar Fasciitis, Chronic
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Ibrahim Abuomar Fadulaalhq AlramadhaniUniversity, hospital or other
- Study start
- 1 Jun 2026 (actual)
- Primary completion
- 1 Jun 2026 (actual)
- Study completion
- 1 Jul 2026 (estimated)
- First posted
- 26 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Plantar fasciitis is a common painful condition. It accounts for 10-15% of all foot painful conditions. Recently, Extracorporeal shock wave therapy (ESWT) was used as an effective method in treatment of different musculoskeletal disorders. High-intensity laser therapy (HILT) is a relatively recent treatment option that has shown benefits in a wide range of musculoskeletal disorders.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- 3 groups, each group consisted of 20 participants
| Arm | Type | Receives |
|---|---|---|
| Control group | Experimental | Other: conventional physical therapyGroup (A) |
| Extracorporeal shock wave therapy | Experimental | Other: Extracorporeal shock wave therapyGroup (B) |
| High-intensity laser therapy | Experimental | Other: High-intensity laser therapyGroup (C) |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- 1. Patients will be included according to the diagnostic criteria for plantar fasciitis of the American physical therapy association (APTA) (Martin et al., 2014). This criterion includes pain in medial sole and heel of foot: most pronounced in initial steps after a period of inactivity, it also worsens after prolonged weight bearing, pain during palpation and compression of proximal plantar fascia, limited range of motion in active and passive ankle dorsiflexion, positive windlass test.
- 2. Patients will be referred from an orthopedic surgeon with confirmed diagnosis of plantar fasciitis (Bidoki et al., 2024).
- 3. Patients with chronic plantar fasciitis (Duration of patient's symptoms will be more than three months) (Riaz et al., 2023).
- 4. Patients' age will range from 18 to 45 years (Bidoki et al., 2024). 5. Both genders (Riaz et al., 2023). 6. Localized non radiating foot pain with an NPRS more than 5 on the first step in the morning (Riaz et al., 2023).
Key exclusion criteria (8 listed)
- Patients will be excluded if they present any of the following criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| conventional physical therapyexercise | Other | Control group |
| Extracorporeal shock wave therapyESWT | Other | Extracorporeal shock wave therapy |
| High-intensity laser therapyHILT | Other | High-intensity laser therapy |
Primary outcome
Hand held dynamometer
Time frame: 6 weeks
Hand held dynamometer is a portable device, characterized as a low-cost and convenience to assess muscle strength in a clinical setting
Ultrasonography
Time frame: 6 weeks
Ultrasonography is a type of medical imaging device that uses high-frequency sound (ultrasound) waves to produce images of internal organs and other tissues such as tendons, muscles, joints, blood vessels, and internal organs, to measure some characteristics
Arabic version of foot function index (FFI-Ar)
Time frame: 6 weeks
Foot functional index is a self-administered index consisting of 23 items divided into 3 subcategories on the basis of: pain, disability and activity limitation.
Arabic version of numerical pain rating scale (NPRS-Ar)
Time frame: 6 weeks
The Numerical Rating Scale is an 11-point (0-10) Scale that measures pain intensity, it is considered a very sensitive pain assessment scale.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2026.
- Individual participant dataSharing planned: No. Because it is top secrets for them and they refused.
Related trials for Plantar Fasciitis, Chronic
Not yet recruiting
Hip Muscle Strengthening and Calf Myofascial Release in Females With Chronic Plantar Fasciitis
Chronic Planter Fascitis
Recruiting
F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection
Plantar Fascitis, Chronic Heel Pain
Not yet recruiting
Radial vs Focused Shockwave Therapy for Plantar Fasciitis
Plantar Fasciitis, Chronic
RecruitingObservational study
Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis
Plantar Fasciitis, Chronic, Tibial Nerve
Recruiting
Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis
Plantar Fasciitis, Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing conventional physical therapy, Extracorporeal shock wave therapy and High-intensity laser therapy in people with Plantar Fasciitis, Chronic, run by Ibrahim Abuomar Fadulaalhq Alramadhani at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hand held dynamometer (time frame: 6 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.